We are live on ! Find out more
RYZB

RayzeBio, Inc. Common Stock

Delisted

RYZB was delisted on the 23rd of February, 2024.

Fund managers haven’t disclosed any holdings of RYZB yet.

RYZB Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in RayzeBio, Inc. Common Stock (RYZB) for Q1 2024, worth a combined $0 — down 100% from $3.41B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of RYZB and 0 opened new positions — a net loss of 106 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $413M sold.

  • 0 institutional investors held RayzeBio, Inc. Common Stock (RYZB) as of Q1 2024, down from 107 in Q4 2023.
  • Funds reported $0 of RayzeBio, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new RayzeBio, Inc. Common Stock positions in Q1 2024 and 106 closed out, a net change of -106 holders.
  • The largest RayzeBio, Inc. Common Stock seller in Q1 2024 was Viking Global Investors, an estimated $413M sold.

Based on aggregated 13F filings for Q1 2024.